Video

Pieter Muntendam: Reducing Patients' Hospital Stay

Author(s):

Pieter Muntendam, MD, scPharmaceuticals, and colleagues hoped their productive can help reduce patients' length of stay in the hospital.

Pieter Muntendam, MD, scPharmaceuticals, explained that when beginning their research, they had to find a way to reduce the ph level, since it wasn't well tolerated. And, since becoming available early last year, it was found to be well tolerated. Muntendam also discussed two studies that were presented at the Heart Failure Society of America's 20th Annual Scientific Meeting, and was pleased that they both showed exactly what his team had hoped for.

Related Videos
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.